Frontpage » Medications » sorted by date »

'Last resort' antibiotics increasingly used to fight multidrug-resistant bugs

Multidrug-resistant pathogens are becoming more frequent, and the few "last resort" treatments available for infections with these bacteria have also shown an increase in use in recent years, according to a study published ...

Medications created 4 hours ago | popularity not rated yet | comments 0

Study finds common antibiotic azithromycin carries heart risk

Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...

Medications created 4 hours ago | popularity not rated yet | comments 0 | with audio podcast

In drug-approval race, US FDA ahead of Canada, Europe

The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters ...

Medications created 4 hours ago | popularity not rated yet | comments 0 | with audio podcast

Too many drugs for many older patients

Older patients are increasingly prescribed multiple drugs that, when combined, can lead to negative side effects and poor health outcomes.  A new Cochrane Library evidence review reveals that little is kno ...

Medications created 12 hours ago | popularity not rated yet | comments 0

Plavix's new generic status could be boon for patients

(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable.

Medications created May 15, 2012 | popularity not rated yet | comments 0


  • Pages: 1